Objective: The purpose of this study was to assess the efficacy of monochromatic UVA laser in the treatment of palmoplantar pustular psoriasis (PPP). Background data: UVA-1 laser (355 nm) has been reported to be safe and effective in the treatment of psoriasis, but the range of potential applications has not been fully explored. Methods: Thirty-three patients were enrolled in an open prospective study. Patients were treated from two to four times weekly at a fixed dose of 80-140 J/cm2. Follow-up was 3 months. Clinical remission was observed in all patients who completed the study, with limited side effects (mild post-treatment erythema). Conclusions: We report for the first time that UVA-1 laser produces a therapeutic response in PPP. © Copyright 2013, Mary Ann Liebert, Inc. 2013.
Nistico, S. P., Saraceno, R., Chiricozzi, A., Giunta, A., Di Stefani, A., Zerbinati, N., UVA-1 Laser in the treatment of palmoplantar pustular psoriasis, <<PHOTOMEDICINE AND LASER SURGERY>>, 2013; 31 (9): 434-438. [doi:10.1089/pho.2013.3545] [http://hdl.handle.net/10807/200337]
UVA-1 Laser in the treatment of palmoplantar pustular psoriasis
Chiricozzi, Andrea;Di Stefani, Alessandro;
2013
Abstract
Objective: The purpose of this study was to assess the efficacy of monochromatic UVA laser in the treatment of palmoplantar pustular psoriasis (PPP). Background data: UVA-1 laser (355 nm) has been reported to be safe and effective in the treatment of psoriasis, but the range of potential applications has not been fully explored. Methods: Thirty-three patients were enrolled in an open prospective study. Patients were treated from two to four times weekly at a fixed dose of 80-140 J/cm2. Follow-up was 3 months. Clinical remission was observed in all patients who completed the study, with limited side effects (mild post-treatment erythema). Conclusions: We report for the first time that UVA-1 laser produces a therapeutic response in PPP. © Copyright 2013, Mary Ann Liebert, Inc. 2013.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
